ArticleScientific reports2025
Development and In Vivo evaluation of liposomal fentanyl nanocarriers using thin-film hydration and AI-based characterization for enhanced analgesic efficacy in anesthesia.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integration of Artificial Intelligence and Microfluidics for Drug Delivery Applications.Micromachines · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this study was to develop and evaluate a liposomal formulation of fentanyl to improve its analgesic efficacy and safety profile in anesthesia, using artificial intelligence (AI) techniques to characterize and optimize the formulation. The liposomes were prepared using the thin-film hydration method, resulting in vesicles with an average diameter of 120.4 ± 10.2 nm and a polydispersity index of 0.23 ± 0.05. The encapsulation efficiency of fentanyl was determined by high performance liquid chromatography (HPLC) and was 85.0 ± 3.2%. A convolutional neural network (CNN) implemented in TensorFlow/Keras (Python) was used for automated analysis of scanning electron microscopy (SEM) images to evaluate the morphology of liposomes. In vitro drug release was studied over 12 hours using a dialysis method. The analgesic efficacy and safety of the liposomal formulation was evaluated in a rat pain model by comparing the paw withdrawal latency (PWL) and mechanical thresholds of Frey with standard fentanyl. A Gaussian Process Regression (GPR) model developed using scikit-learn (Python) was used to predict liposome properties based on formulation parameters. CNN analysis confirmed predominantly spherical liposomes with 3.2% aggregates and 1.8% broken particles. In vitro release studies showed sustained release of fentanyl with an initial burst of approximately 10%. In vivo, the liposomal fentanyl group showed significantly prolonged analgesia (PWL: 12.4 ± 2.1 seconds) compared to standard fentanyl (8.5 ± 1.5 seconds, p < 0.05), with no observed respiratory depression or sedation. The GPR model demonstrated strong predictive performance (R
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.